MétaCan
Menu
Back to cohort

The Safety and Effectiveness of Bempedoic Acid in Cholesterol Management: A Systematic Review

2025· review· en· W4408233527 on OpenAlexaboutno aff
Dr Ghulam Murtaza, Dr Fazeela Asim, Dr Sumara Nawaz, Dr Tayyaba Mustafa Mian

Bibliographic record

VenueSAS Journal of Medicine · 2025
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicNatural product bioactivities and synthesis
Canadian institutionsnot available
Fundersnot available
KeywordsMedicine

Abstract

fetched live from OpenAlex

The effectiveness, safety and usage of bempedoic acid in controlling hypercholesterolemia and lowering cardiovascular risk are assessed in this systematic review. It comprises of 15 trials evaluating cardiovascular outcomes, adverse events, and improvements in lipid profiles. Bempedoic acid showed significant decrease in non-HDL-C, total cholesterol, LDL-C, and CRP levels. While effective, some studies noted side effects, such as gout flare-ups and elevated uric acid levels. Overall, bempedoic acid is a promising treatment option with manageable safety risks, particularly for statin-intolerant patients. Background: Elevated cholesterol levels is a critical risk factor in cardiovascular disease. While statins are effective, some patients cannot tolerate them due to statin intolerance, necessitating alternative therapies. Bempedoic acid, an innovative oral ATP-citrate lyase inhibitor, has emerged as a viable option. This review synthesizes existing data to evaluate its efficacy and safety in cholesterol management. Method: This review included systematic reviews, meta-analyses, and randomized controlled trials reported between 2019 and 2024. Peer-reviewed studies focused on bempedoic acid's efficacy and safety in various populations. Data were extracted on study design, population characteristics, interventions, and outcomes, including lipid profiles, CRP levels, and MACE. The Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale were used to assess the quality of the study ensuring consistent, reliable data extraction. Result: The systematic review revealed that bempedoic acid efficiently lowers levels of LDL-C, total cholesterol, CRP and non-HDLC; its effectiveness is increased by combination therapy. It considerably decreased the incidence of myocardial infarction and other major adverse cardiovascular events (MACE) in high-risk populations, even though frequent side effects such flare-ups of gout and higher uric acid levels were observed. Conclusion: Bempedoic

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.009
metaresearch head score (Gemma)0.036
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.011
Threshold uncertainty score0.048

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0090.036
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0110.010
Bibliometrics0.0080.008
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0020.001
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.301
Teacher spread0.293 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueSAS Journal of MedicineSame topicNatural product bioactivities and synthesisFrench-language works237,207